GB Sciences (OTCQB: GBLX) is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market. President & Chief Scientific Officer, Andrea Small-Howard, joins us to discuss how the company differentiates itself in the crowded biopharmaceutical field.

View Podcast Transcript